Amit Sachdev, EVP, Chief Patient Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 19,330 shares at $279.67 ($5.5M) on 2020-05-11, disclosed to the SEC on 2020-05-13.
Seasonal sale ($5.5M) by EVP, Chief Patient Officer — this insider has traded VRTX in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $276.25 | 800 | $221K | 4.0% |
| 2 | $277.38 | 201 | $56K | 1.0% |
| 3 | $277.38 | 201 | $56K | 1.0% |
| 4 | $279.67 | 655 | $183K | 3.4% |
| 5 | $279.67 | 655 | $183K | 3.4% |
| 6 | $280.77 | 1,817 |
| $510K |
| 9.3% |
| 7 | $280.77 | 1,817 | $510K | 9.3% |
| 8 | $281.74 | 1,398 | $394K | 7.2% |
| 9 | $281.74 | 1,398 | $394K | 7.2% |
| 10 | $282.89 | 913 | $258K | 4.7% |
| 11 | $282.89 | 913 | $258K | 4.7% |
| 12 | $283.98 | 1,100 | $312K | 5.7% |
| 13 | $285.15 | 2,314 | $660K | 12.1% |
| 14 | $285.15 | 2,314 | $660K | 12.1% |
| 15 | $285.94 | 1,367 | $391K | 7.2% |
| 16 | $285.94 | 1,367 | $391K | 7.2% |
| 17 | $286.72 | 100 | $29K | 0.5% |
| Total | $282.77 avg | 19,330 | $5.5M | 100% |
| Filing → |
| VRTX | SELL | 2024-05-17 | $14K | — | Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |